Expanding the phenotypic spectrum of Mabry Syndrome with novel PIGO gene variants associated with hyperphosphatasia, intractable epilepsy, and complex gastrointestinal and urogenital malformations

Eur J Med Genet. 2020 Apr;63(4):103802. doi: 10.1016/j.ejmg.2019.103802. Epub 2019 Nov 5.

Abstract

Mabry syndrome is a glycophosphatidylinositol (GPI) deficiency characterized by intellectual disability, distinctive facial features, intractable seizures, and hyperphosphatasia. We expand the phenotypic spectrum of inherited GPI deficiencies with novel bi-allelic phosphatidylinositol glycan anchor biosynthesis class O (PIGO) variants in a neonate who presented with intractable epilepsy and complex gastrointestinal and urogenital malformations.

Keywords: Anal atresia; Epilepsy; Esophageal atresia; GPI anchor; Glycophosphatidylinositol; Mabry syndrome; PIGO; VACTERL.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Drug Resistant Epilepsy / genetics*
  • Female
  • Gastrointestinal Tract / abnormalities
  • Genetic Variation
  • Glycosylphosphatidylinositols / deficiency*
  • Humans
  • Infant, Newborn
  • Intellectual Disability / genetics*
  • Membrane Proteins / genetics*
  • Phenotype
  • Phosphorus Metabolism Disorders / genetics*
  • Urogenital Abnormalities / genetics*

Substances

  • Glycosylphosphatidylinositols
  • Membrane Proteins
  • PIGO protein, human

Supplementary concepts

  • Hyperphosphatasia with Mental Retardation